Imaging Insights: ARIA Identification in Early Symptomatic Alzheimer's Disease is organized by Medical Learning Institute Inc (MLI).
Release Date: Apr 06, 2026
Expiration Date: Apr 05, 2027
Description:
Imaging Insights: ARIA Identification in Early Symptomatic Alzheimer’s Disease provides imaging physicians with essential education to strengthen their role in caring for patients receiving amyloid-targeting therapies (ATTs). This ISS focuses on understanding the pathophysiology and risk factors associated with amyloid-related imaging abnormalities (ARIA), implementing standardized MRI protocols and grading scales to improve detection and severity assessment, and enhancing interdisciplinary communication to support timely management. As ATTs become more widely used, radiologists, neuroradiologists, and imaging trainees worldwide face critical knowledge and practice gaps that can delay ARIA recognition and disrupt patient care.?This activity addresses these needs by equipping imaging specialists with the tools and strategies necessary for consistent monitoring, accurate reporting, and effective collaboration, ultimately promoting safer and more coordinated care for patients with early symptomatic Alzheimer’s disease.
Learning Objectives:
After completing this activity, the participant should be better able to:
Credits:
In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education:
Medical Learning Institute Inc (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 1.0 hours of effective education time.
EBAC® holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively.
Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) and the American Medical Association, physicians may convert EBAC® External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other healthcare professionals may obtain from the AMA a certificate of participation in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.
EBAC® is a member of the International Academy for CPD Accreditation (IACPDA), the World Federation for Medical Education (WFME) CPD Recognition Committee, and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).
PA:
Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until April 5, 2027. PAs should only claim credit commensurate with the extent of their participation.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved